$EXPO
EXPONENT INC

2014 Q4 Form 10-Q Financial Statement

#000114420414066089 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q1 2013 Q3
Revenue $78.56M $72.80M $75.23M
YoY Change 0.19% 2.64%
Cost Of Revenue $4.300M $3.700M $5.100M
YoY Change 0.0% -22.73%
Gross Profit $74.30M $69.00M $70.10M
YoY Change 0.0% 5.1%
Gross Profit Margin 94.58% 94.78% 93.18%
Selling, General & Admin $48.30M $50.20M $48.50M
YoY Change -3.46% 5.21%
% of Gross Profit 65.01% 72.75% 69.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.300M $1.300M
YoY Change 18.18% 8.33%
% of Gross Profit 1.88% 1.88% 1.85%
Operating Expenses $59.32M $56.70M $60.07M
YoY Change -8.27% 2.56%
Operating Profit $19.24M $12.30M $15.16M
YoY Change 13.35% 2.93%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit 0.0% 0.0% 0.0%
Other Income/Expense, Net -$863.0K $2.300M $2.355M
YoY Change -13.34% 47.0%
Pretax Income $18.38M $14.70M $17.52M
YoY Change 8.85% 7.26%
Income Tax $7.335M $5.900M $6.421M
% Of Pretax Income 39.92% 40.14% 36.66%
Net Earnings $11.04M $8.700M $11.09M
YoY Change 9.08% 8.5%
Net Earnings / Revenue 14.05% 11.95% 14.75%
Basic Earnings Per Share $0.41 $0.82
Diluted Earnings Per Share $0.40 $155.9K $0.79
COMMON SHARES
Basic Shares Outstanding 26.94M shares 13.06M shares 13.60M shares
Diluted Shares Outstanding 27.65M shares 13.99M shares

Balance Sheet

Concept 2014 Q4 2014 Q1 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $141.6M $156.1M $135.0M
YoY Change 40.63% 23.06%
Cash & Equivalents $44.20M $122.9M $121.7M
Short-Term Investments $26.00M $33.20M $13.30M
Other Short-Term Assets $23.70M $18.60M $17.80M
YoY Change 24.0% 21.09%
Inventory
Prepaid Expenses
Receivables $89.10M $76.98M $82.20M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $254.5M $251.7M $235.0M
YoY Change 21.82% 9.09%
LONG-TERM ASSETS
Property, Plant & Equipment $28.80M $28.72M $28.40M
YoY Change 1.49% 4.49%
Goodwill $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.20M $551.0K $52.50M
YoY Change -98.93% 6202.52%
Total Long-Term Assets $97.56M $92.48M $89.50M
YoY Change 4.62% 14.51%
TOTAL ASSETS
Total Short-Term Assets $254.5M $251.7M $235.0M
Total Long-Term Assets $97.56M $92.48M $89.50M
Total Assets $352.1M $344.2M $324.5M
YoY Change 16.67% 10.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.00M $2.798M $5.100M
YoY Change -60.03% -50.0%
Accrued Expenses $54.50M $5.644M $47.60M
YoY Change -81.43% 10.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.36M $72.15M $58.90M
YoY Change 68.57% 0.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.613M $1.181M $34.90M
YoY Change -96.53% 3304.88%
Total Long-Term Liabilities $1.613M $1.181M $34.90M
YoY Change -96.53% 3304.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.36M $72.15M $58.90M
Total Long-Term Liabilities $1.613M $1.181M $34.90M
Total Liabilities $111.5M $109.1M $93.80M
YoY Change 41.88% 9.78%
SHAREHOLDERS EQUITY
Retained Earnings $241.1M $226.0M $219.5M
YoY Change 10.44%
Common Stock $158.9M $141.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $159.1M $132.4M
YoY Change
Treasury Stock Shares 3.519M shares 3.363M shares
Shareholders Equity $240.5M $235.1M $230.6M
YoY Change
Total Liabilities & Shareholders Equity $352.1M $344.2M $324.5M
YoY Change 16.67% 10.53%

Cashflow Statement

Concept 2014 Q4 2014 Q1 2013 Q3
OPERATING ACTIVITIES
Net Income $11.04M $8.700M $11.09M
YoY Change 9.08% 8.5%
Depreciation, Depletion And Amortization $1.400M $1.300M $1.300M
YoY Change 18.18% 8.33%
Cash From Operating Activities $15.40M $28.00M $17.40M
YoY Change -638.46% 690.91%
INVESTING ACTIVITIES
Capital Expenditures $1.930M -$1.600M $892.0K
YoY Change -181.67% -39.85%
Acquisitions
YoY Change
Other Investing Activities $5.400M -$20.10M -$6.900M
YoY Change -279.46% -400.0%
Cash From Investing Activities $3.500M -$21.70M -$7.800M
YoY Change -333.33% -1075.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.00M -5.600M -5.200M
YoY Change -63.16% 2500.0%
NET CHANGE
Cash From Operating Activities 15.40M 28.00M 17.40M
Cash From Investing Activities 3.500M -21.70M -7.800M
Cash From Financing Activities -15.00M -5.600M -5.200M
Net Change In Cash 3.900M 700.0K 4.400M
YoY Change -106.31% 57.14%
FREE CASH FLOW
Cash From Operating Activities $15.40M $28.00M $17.40M
Capital Expenditures $1.930M -$1.600M $892.0K
Free Cash Flow $13.47M $29.60M $16.51M
YoY Change -513.47% 2202.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15160000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
551000 USD
CY2014Q4 us-gaap Assets
Assets
352056000 USD
CY2014Q1 us-gaap Assets
Assets
344166000 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11011000 USD
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8442000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54496000 USD
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56934000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5848000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6771000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71355000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
72147000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1613000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1181000 USD
CY2014Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
36384000 USD
CY2014Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
33447000 USD
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2162000 USD
CY2014Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2332000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
111514000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
109107000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158909000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
141250000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-372000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-353000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
109000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
241074000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
226040000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q4 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
159104000 USD
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
132356000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
240542000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
235059000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
352056000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
344166000 USD
CY2014Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2014Q4 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2014Q4 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3241000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2771000 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3519000 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3363000 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
211007000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
11531000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
12389000 USD
CY2013Q3 us-gaap Revenues
Revenues
75231000 USD
us-gaap Revenues
Revenues
231093000 USD
us-gaap Revenues
Revenues
223396000 USD
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
44801000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
138855000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
137795000 USD
CY2013Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6440000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19482000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18794000 USD
CY2013Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
5135000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
11531000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
12389000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3695000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11809000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10814000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
60071000 USD
us-gaap Operating Expenses
OperatingExpenses
181677000 USD
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2014Q4 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
0 USD
us-gaap Investment Income Net
InvestmentIncomeNet
95000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2605000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5592000 USD
CY2014Q4 us-gaap Revenues
Revenues
78557000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2355000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2722000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5687000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
49291000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6421000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20680000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19373000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
11094000 USD
us-gaap Net Income Loss
NetIncomeLoss
31458000 USD
us-gaap Net Income Loss
NetIncomeLoss
29918000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.13
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13598000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13509000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13638000 shares
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19238000 USD
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13993000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13889000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14047000 shares
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1930000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4593000 USD
CY2014Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1346000 USD
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1283000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3979000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3667000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2014Q4 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2014Q4 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2013Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2014Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
556000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-471000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-25000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11647000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30996000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30012000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-660000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-165000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-170000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17027000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1234000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
822000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6008000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
5807000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10585000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10832000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
884000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
17458000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
164000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6046000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2770000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5126000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4064000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13343000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2362000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2877000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3498000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6314000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-521000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
331000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3469000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-923000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-510000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
26076000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
33818000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1067000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
11813000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
7586000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
19190000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2613000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2784000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5126000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4064000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6356000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6112000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26372000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21719000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1811000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1497000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
9842000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
5962000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-35633000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-28232000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-390000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
109000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7334000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8479000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113268000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121747000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21211000 USD
CY2014Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
38077000 USD
CY2013Q3 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
140000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
6050000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
10253000 USD
CY2014Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74264000 USD
CY2014Q4 us-gaap Reimbursement Revenue
ReimbursementRevenue
4293000 USD
CY2014Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
43948000 USD
CY2014Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6715000 USD
CY2014Q4 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4293000 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4363000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
59319000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
383639 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27923000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
388604 shares
CY2014Q4 us-gaap Investment Income Net
InvestmentIncomeNet
33000 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-896000 USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-863000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18375000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7335000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
11040000 USD
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13469000 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13824000 shares
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2014Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10187000 USD
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2014Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2014Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2014Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2014Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3270000 USD
CY2014Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9794000 USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1945000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1965000 USD
CY2014 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7877000 USD
CY2006Q2 expo Authorized Common Stock Shares Limit On Use
AuthorizedCommonStockSharesLimitOnUse
40000000 shares
CY2006Q2 expo Authorized Preferred Stock Shares Limit On Use
AuthorizedPreferredStockSharesLimitOnUse
2000000 shares
CY2014Q4 expo Common Stock Dividends Per Share Declared Subsequent Event
CommonStockDividendsPerShareDeclaredSubsequentEvent
0.25
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-840000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1969000 USD
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1998000 USD
CY2014Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
156103000 USD
CY2014Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
25000 USD
CY2014Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
9000 USD
CY2014Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
156119000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
44246000 USD
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
112353000 USD
CY2014Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
43832000 USD
CY2014Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
43832000 USD
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2014Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
37099000 USD
CY2014Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
108249000 USD
CY2014Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
37926000 USD
CY2014Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
37926000 USD
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
141591000 USD
CY2014Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
36000 USD
CY2014Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4000 USD
CY2014Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
141623000 USD
CY2014Q4 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
18873000 USD
CY2014Q4 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
18897000 USD
CY2014Q4 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
7104000 USD
CY2014Q4 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
7112000 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
25977000 USD

Files In Submission

Name View Source Status
0001144204-14-066089-index-headers.html Edgar Link pending
0001144204-14-066089-index.html Edgar Link pending
0001144204-14-066089.txt Edgar Link pending
0001144204-14-066089-xbrl.zip Edgar Link pending
expo-20141003.xml Edgar Link completed
expo-20141003.xsd Edgar Link pending
expo-20141003_cal.xml Edgar Link unprocessable
expo-20141003_def.xml Edgar Link unprocessable
expo-20141003_lab.xml Edgar Link unprocessable
expo-20141003_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v392158_10q.htm Edgar Link pending
v392158_ex31-1.htm Edgar Link pending
v392158_ex31-2.htm Edgar Link pending
v392158_ex32-1.htm Edgar Link pending
v392158_ex32-2.htm Edgar Link pending